logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
S

Stephen Opat

Monash University and Monash Health

40H-index
359Paper Count
1.1WCitation Count
Published Papers 72
Publication Date
logo
End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study
errBritish Journal of Haematology
IF3.8
err2026-08-21
err0
PREAI
errChathuri Abeyakoon; Cameron Wellard; Vanessa Murad; Eliza Chung; David Hodgson; Danielle Rodin; Anca Prica; Tomohiro Aoki; Abi Vijenthira; Umberto Falcone; Stephen Opat; Erica M. Wood; Zoe K. McQuilten; Eliza A. Hawkes; Michael Crump; John Kuruvilla; Gareth P. Gregory
errShare
errSave
Coronavirus disease 2019 (COVID-19) risk and evolving treatment patterns in follicular lymphoma during the pandemic: Insights from the PETReA trial
errBritish Journal of Haematology
IF3.8
err2026-08-21
err0
PREAI
errS. Williams; Y. J. Lim; R. Cooper; C. Gamble; H. Short; A. Arumainathan; T. A. Eyre; P. McKay; M. Young; M. Bishton; S. Gatto; M. Macheta; A. Zhelyazkova; E. Heartin; F. Miall; V. Warbey; S. Opat; A. Johnston; J. Trotman; K. Linton; A. Pettitt
errShare
errSave
Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial
errBlood
IF23.1
err2026-03-04
err0
errOAAI
errJeff P. Sharman; Luca Laurenti; Emmanuelle Ferrant; Luis Felipe Casado Montero; Stephen P. Mulligan; Rosemary Harrup; Stephen Opat; Adalberto Ibatici; Roberto Marasca; Paolo Sportoletti; Maria Thadani-Mulero; Oscar Cazares; Weize Huang; Yanwen Jiang; Emma Clark; Hyun Yong Jin; Michelle Boyer; Franck Morschhauser
errShare
errSave
Development and Validation of Prognostic Models for Treatment Response of Patients with B-Cell Lymphoma: Standard Statistical and Machine-Learning Approaches
errJournal of Clinical Medicine
IF2.9
err2026-03-03
err0
errOAAI
errAdugnaw Zeleke Alem; Itismita Mohanty; Nalini Pati; Cameron Wellard; Eliza Chung; Eliza A. Hawkes; Zoe K. McQuilten; Erica M. Wood; Stephen Opat; Theophile Niyonsenga
errShare
errSave
Outcomes following transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from ASPEN
errBlood Advances
IF7.1
err2025-09-11
err0
errOAAI
errRamón García-Sanz; Roger G. Owen; Wojciech Jurczak; Meletios A. Dimopoulos; Helen McCarthy; Gavin Cull; Stephen S. Opat; Jorge J. Castillo; Marie José Kersten; Björn E. Wahlin; Sebastian Grosicki; Radha Prathikanti; Tian Tian; Heather Allewelt; Aileen Cleary Cohen; Constantine S. Tam
errShare
errSave
Zanubrutinib in the treatment of Waldenström Macroglobulinemia
errFuture Oncology
IF2.6
err2025-09-11
err0
errOAAI
errElizabeth Goodall; Stephen Opat
errShare
errSave
Too soon to reject immunoglobulin replacement in CLL
errBlood Advances
IF7.1
err2025-09-03
err0
errOAAI
errStephen Opat; Ross Salvaris
errShare
errSave
Zanubrutinib in the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies
errBlood Advances
IF7.1
err2025-08-22
err0
errOAAI
errConstantine S. Tam; Mary Ann Anderson; Martin Šimkovič; Paolo Ghia; Ian W. Flinn; Kamel Laribi; Stephen Opat; Gavin Cull; Talha Munir; Anders Österborg; Alessandra Tedeschi; Megan Wang; Andy Szeto; Heather Allewelt; Tommi Salmi; Jessica Li; Linlin Xu; Ken Wu; Remus Vezan; Mazyar Shadman; Jennifer R. Brown
errShare
errSave
Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia
errBLOOD ADVANCES
IF7.1
err2025-02-12
err2
errOAAI
errHeyman, Benjamin M.; Opat, Stephen S.; Wahlin, Bjorn E.; Dimopoulos, Meletios-Athanasios C.; Castillo, Jorge J.; Tedeschi, Alessandra; Tam, Constantine S.; Buske, Christian; Owen, Roger G.; Leblond, Veronique ronique; Trotman, Judith; Barnes, Gisoo; Chan, Wai Y.; Schneider, Jingjing; Allewelt, Heather; Cohen, Aileen; V. Matous, Jeffrey
errShare
errSave
CRISTALLO: Results from a Phase III Trial of Venetoclax-Obinutuzumab Versus Fludarabine, Cyclophosphamide and Rituximab or Bendamustine-Rituximab in Patients with Untreated Chronic Lymphocytic Leukemia without Del(17p) or TP53 Mutations
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errSharman, Jeff P.; Laurenti, Luca; Ferrant, Emmanuelle; Montero, Luis Felipe Casado; Mulligan, Stephen P.; Harrup, Rosemary; Opat, Stephen; Ibatici, Adalberto; Marasca, Roberto; Sportoletti, Paolo; Lefebure, Marcus; Boyer, Michelle; Jiang, Yanwen; Barlera, Simona; Cazares, Oscar; Morschhauser, Franck
errShare
errSave
Long-Term Impact of Dose Interruptions (DIs) of Bruton Tyrosine Kinase Inhibitors (BTKis) on Change in IgM Levels and Clinical Outcomes in Waldenström Macroglobulinemia (WM)
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errTrotman, Judith; Rankin, Katherine; Tohidi-Esfahani, Ibrahim; Tedeschi, Alessandra; Tam, Constantine S.; Buske, Christian; Owen, Roger G.; Leblond, Veronique; Dimopoulos, Meletios A.; Smallwood, Peter; Allewelt, Heather; Chan, Wai Y.; Prathikanti, Radha; Schneider, Jingjing; Vezan, Remus; Opat, Stephen S.
errShare
errSave
BGB-11417-203, an Ongoing, Phase 2 Study of Sonrotoclax (BGB-11417), a Next-Generation BCL2 Inhibitor, in Patients With Waldenström Macroglobulinemia
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errLee, Hui-Peng; Opat, Stephen S.; Hrom, John; Kliman, David; Marlton, Paula; Liu, Peng; Du, Chenmu; Lussier, Amber; Zhang, Jun; Guo, Haiyi; Treon, Steven P.
errShare
errSave
Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia
errBMC CANCER
IF3.4
err2024-07-11
err2
errOAAI
errFifer, Simon; Godsell, Jenni; Opat, Stephen; Hamad, Nada; Lasica, Masa; Forsyth, Cecily; Morand, Louisa; Smeaton, Erica; Winton, Sharon; Puig, Andrea; Mcgeachie, Marija
errShare
errSave
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia
errBLOOD ADVANCES
IF7.1
err2024-03-28
err3
errOAAI
errTam, Constantine S.; Opat, Stephen; D'Sa, Shirley; Jurczak, Wojciech; Lee, Hui-Peng; Cull, Gavin; Owen, Roger G.; Marlton, Paula; Wahlin, Bjoern E.; Garcia-Sanz, Ramon; McCarthy, Helen; Mulligan, Stephen; Tedeschi, Alessandra; Castillo, Jorge J.; Czyz, Jaros law; De Larrea, Carlos Fernandez; Belada, David; Libby, Edward; Matous, Jeffrey; Motta, Marina; Siddiqi, Tanya; Tani, Monica; Trneny, Marek; Minnema, Monique C.; Buske, Christian; Leblond, Veronique; Treon, Steven P.; Trotman, Judith; Wu, Binghao; Yu, Yiling; Shen, Zhirong; Chan, Wai Y.; Schneider, Jingjing; Allewelt, Heather; Cohen, Aileen; Dimopoulos, Meletios A.
errShare
errSave
Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study
errHAEMATOLOGICA
IF7.9
err2024-03-07
err4
errOAAI
errBarraclough, Allison; Agrawal, Shivam; Talaulikar, Dipti; Chong, Geoffrey; Yoo, Edward; Cheah, Chan Y.; Franco, Nunzio; Nguyen, Bianca; Mutsando, Howard; Tahir, Fatima; Trotman, Judith; Huang, Jing; Keane, Colm; Lincoln, Mitchel; Cochrane, Tara; Johnston, Anna M.; Dickinson, Michael; Opat, Stephen; McQuilten, Zoe K.; Wood, Erica M.; St George, Gayathri; Hawkes, Eliza A.
errShare
errSave
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study
errBLOOD ADVANCES
IF7.1
err2023-11-15
err10
errOAAI
errOpat, Stephen; Tedeschi, Alessandra; Hu, Bei; Linton, Kim M.; Mckay, Pamela; Leitch, Sophie; Coleman, Morton; Zinzani, Pier Luigi; Jin, Jie; Sun, Mingyuan; Sobieraj-Teague, Magdalena; Browett, Peter; Ke, Xiaoyan; Thieblemont, Catherine; Ardeshna, Kirit; Bijou, Fontanet; Walker, Patricia; Hawkes, Eliza A.; Ho, Shir-Jing; Zhou, Keshu; Liang, Zhiyu; Xu, Jianfeng; Tankersley, Chris; Delarue, Richard; Co, Melannie; Trotman, Judith
errShare
errSave
A Population-Based Family Case-Control Study of Sun Exposure and Follicular Lymphoma Risk
errCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
IF3.4
err2023-10-13
err1
errOAAI
errOdutola, Michael K.; van Leeuwen, Marina T.; Bruinsma, Fiona; Turner, Jennifer; Hertzberg, Mark; Seymour, John F.; Prince, H. Miles; Trotman, Judith; Verner, Emma; Roncolato, Fernando; Opat, Stephen; Lindeman, Robert; Tiley, Campbell; Milliken, Samuel T.; Underhill, Craig R.; Benke, Geza; Giles, Graham G.; Vajdic, Claire M.
errShare
errSave
Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study
errHAEMATOLOGICA
IF7.9
err2023-09-28
err4
errOAAI
errFlowers, Christopher R.; Matasar, Matthew J.; Herrera, Alex F.; Hertzberg, Mark; Assouline, Sarit; Demeter, Judit; Mcmillan, Andrew; Mehta, Amitkumar; Opat, Stephen; Trneny, Marek; Musick, Lisa; Hirata, Jamie; Yang, Annie; Sehn, Laurie H.
errShare
errSave
Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case-control study
errOCCUPATIONAL AND ENVIRONMENTAL MEDICINE
IF3.1
err2023-09-18
err0
errOAAI
errOdutola, Michael K.; van Leeuwen, Marina T.; Bruinsma, Fiona J.; Benke, Geza; Turner, Michelle C.; Trotman, Judith; Turner, Jennifer; Seymour, John F.; Prince, H. Miles; Milliken, Samuel T.; Tiley, Campbell; Hertzberg, Mark; Roncolato, Fernando; Opat, Stephen; Lindeman, Robert; Verner, Emma; Underhill, Craig R.; Cardis, Elisabeth; Giles, Graham; Vajdic, Claire M.
errShare
errSave
Zanubrutinib: past, present, and future
errBLOOD CANCER JOURNAL
IF11.6
err2023-09-11
err16
errOAAI
errTam, Constantine S.; Munoz, Javier L.; Seymour, John F.; Opat, Stephen
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
G
Graham G. Giles
H-index: 164 · Papers: 2.4K
M
Meletios Α. Dimopoulos
H-index: 159 · Papers: 3.0K
H
Hartmut Döhner
H-index: 146 · Papers: 1.4K
A
Andreas Strasser
H-index: 135 · Papers: 815
G
Gilles Salles
H-index: 129 · Papers: 1.7K
View more